BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 33815311)

  • 1. Carbonic Anhydrases: New Perspectives on Protein Functional Role and Inhibition in
    Campestre C; De Luca V; Carradori S; Grande R; Carginale V; Scaloni A; Supuran CT; Capasso C
    Front Microbiol; 2021; 12():629163. PubMed ID: 33815311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of novel antimicrobial carbonic anhydrase inhibitors.
    Supuran CT
    Expert Opin Ther Targets; 2023; 27(10):897-910. PubMed ID: 37747071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial, fungal and protozoan carbonic anhydrases as drug targets.
    Capasso C; Supuran CT
    Expert Opin Ther Targets; 2015; 19(12):1689-704. PubMed ID: 26235676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?
    Supuran CT
    Front Pharmacol; 2011; 2():34. PubMed ID: 21779249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial carbonic anhydrase inhibitors: an update on the recent literature.
    Supuran CT; Capasso C
    Expert Opin Ther Pat; 2020 Dec; 30(12):963-982. PubMed ID: 32806966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs.
    Supuran CT
    Curr Med Chem; 2012; 19(6):831-44. PubMed ID: 22214451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Inhibition of
    Grande R; Carradori S; Puca V; Vitale I; Angeli A; Nocentini A; Bonardi A; Gratteri P; Lanuti P; Bologna G; Simeone P; Capasso C; De Luca V; Supuran CT
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769015
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors.
    Supuran CT
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3467-74. PubMed ID: 20529676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedical applications of prokaryotic carbonic anhydrases.
    Supuran CT; Capasso C
    Expert Opin Ther Pat; 2018 Oct; 28(10):745-754. PubMed ID: 29973089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance.
    Capasso C; Supuran CT
    Curr Top Med Chem; 2017; 17(11):1237-1248. PubMed ID: 28049405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?
    Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):325-32. PubMed ID: 24766661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrases as drug targets--an overview.
    Supuran CT
    Curr Top Med Chem; 2007; 7(9):825-33. PubMed ID: 17504127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of the α-CA in the outer membrane vesicles produced by Helicobacter pylori.
    Ronci M; Del Prete S; Puca V; Carradori S; Carginale V; Muraro R; Mincione G; Aceto A; Sisto F; Supuran CT; Grande R; Capasso C
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):189-195. PubMed ID: 30734607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
    Del Prete S; Vullo D; De Luca V; Carginale V; Osman SM; AlOthman Z; Supuran CT; Capasso C
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1941-6. PubMed ID: 26972117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrases--an overview.
    Supuran CT
    Curr Pharm Des; 2008; 14(7):603-14. PubMed ID: 18336305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrases as targets for medicinal chemistry.
    Supuran CT; Scozzafava A
    Bioorg Med Chem; 2007 Jul; 15(13):4336-50. PubMed ID: 17475500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets.
    Nishimori I; Onishi S; Takeuchi H; Supuran CT
    Curr Pharm Des; 2008; 14(7):622-30. PubMed ID: 18336307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
    Del Prete S; Vullo D; De Luca V; Carginale V; di Fonzo P; Osman SM; AlOthman Z; Supuran CT; Capasso C
    Bioorg Med Chem; 2016 Aug; 24(16):3413-7. PubMed ID: 27283786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
    Ferraroni M; Del Prete S; Vullo D; Capasso C; Supuran CT
    Acta Crystallogr D Biol Crystallogr; 2015 Dec; 71(Pt 12):2449-56. PubMed ID: 26627652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anion Inhibition Studies of the Beta-Carbonic Anhydrase from
    Del Prete S; De Luca V; Nocentini A; Scaloni A; Mastrolorenzo MD; Supuran CT; Capasso C
    Molecules; 2020 May; 25(11):. PubMed ID: 32486444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.